Related Experiment Video
Updated: Jul 11, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Subdural motor cortex stimulation in Parkinson's disease does not modify movement-related rCBF pattern
Antonio P Strafella1, Andres M Lozano, Anthony E Lang
1Movement Disorders Center, Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada. antonio.strafella@uhnres.utoronto.ca
Movement Disorders : Official Journal of the Movement Disorder Society
|September 27, 2007
Summary
Electrical stimulation of the primary motor cortex (MCS) did not improve motor performance or alter brain activity in Parkinson's disease (PD) patients. This study suggests MCS may not be an effective alternative to deep brain stimulation for advanced PD.
Area of Science:
- Neuroscience
- Neurosurgery
- Neurology
Background:
- Parkinson's disease (PD) significantly impacts motor function.
- Electrical stimulation of the primary motor cortex (MCS) is being explored as a potential treatment for PD.
- MCS is considered an alternative for patients unsuitable for deep brain stimulation (DBS) of the subthalamic nucleus (STN).
Purpose of the Study:
- To investigate the effects of unilateral MCS on motor performance and regional cerebral blood flow (rCBF) in PD patients.
- To assess the efficacy of different MCS stimulation frequencies (50 Hz and 130 Hz) compared to an OFF-stimulation condition.
Main Methods:
- Four patients with advanced PD underwent unilateral MCS.
- Positron emission tomography (PET) with [(15)O] H2O was used to measure rCBF during a joystick motor task.
- Motor performance and UPDRS motor scores were evaluated during OFF and ON stimulation conditions, while patients were medication-off.
Main Results:
- No significant improvement in joystick task performance was observed with different MCS stimulation frequencies.
- MCS did not alter the pattern of movement-related rCBF.
- No changes in UPDRS motor scores were detected between OFF and ON stimulation states.
Conclusions:
- Unilateral MCS did not demonstrate a clear effect on motor performance or movement-related brain activation in advanced PD patients.
- While potentially simpler and safer than STN DBS, MCS showed limited efficacy in this study.
- Further research is needed to determine the therapeutic potential of MCS for Parkinson's disease.

